Palisade Bio Inc (PALI)
6.30
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.30
0.00 (0.00%)
After-Hours: 20:00
Palisade Bio Cash and Short Term Investments (Quarterly): 11.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.28M |
| December 31, 2023 | 12.43M |
| September 30, 2023 | 15.31M |
| June 30, 2023 | 16.40M |
| March 31, 2023 | 13.30M |
| December 31, 2022 | 12.38M |
| September 30, 2022 | 13.98M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.98M |
| March 31, 2022 | 6.644M |
| December 31, 2021 | 10.50M |
| September 30, 2021 | 14.10M |
| June 30, 2021 | 12.65M |
| December 31, 2020 | 0.713M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.713M
Minimum
Dec 2020
16.40M
Maximum
Jun 2023
11.13M
Average
12.43M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| TG Therapeutics Inc | 209.78M |
| Protagenic Therapeutics Inc | 4.056M |
| Bio-Path Holdings Inc | 1.052M |
| Jaguar Health Inc | 11.67M |
| Finch Therapeutics Group Inc | 20.76M |